Page 162 - Mployee Wellness Programs News Today

Last fall, AWS announced that it was launching a new accelerator to support startups that develop technology to help the healthcare sector address its challenges with workforce deployment, retention and training. At ViVE, the company unveiled which 23 startups have been selected to take part in the accelerator.

Check out news from VenoVision, Cora Therapeutics, Zorro, and Validic.

Many healthcare workers prefer providing at-home care because it allows them to provide more personal, less hectic care than they can on the hospital floor, said Current Health CEO Chris McGhee. He thinks health systems should realize that switching more healthcare workers to at-home care could help alleviate the burnout crisis and improve staff retention levels.

Cytokinetics drug reldesemtiv has failed a pivotal clinical trial in amyotrophic lateral sclerosis. The small molecule had previously failed in Phase 2, but the biotech believed adjustments could lead to better results in Phase 3.

Atropos Health — a company that delivers clinical data to physicians at the point of care to help them treat complex patients — recently launched a clinical advisory board and new evidence network. Both announcements are meant to enhance the credibility and transparency of its physician consult platform, CEO Brigham Hyde said at ViVE in Nashville.

The financial outlook for the digital health sector is less than ideal, characterized by lower funding amounts, shrinking valuations, dwindling profitability and the collapse of Silicon Valley Bank. During a recent conference panel, four healthcare VCs discussed their reactions to this. They explained why the market has switched its focus from growth to value, as well gave advice to startups about what they need to know in this changing environment.

The recent growth in RPM has demonstrated its importance and potential to reduce or eliminate barriers and improve access to care for patients. By leveraging RPM and other digital health solutions as an important part of a multi-prong approach to care delivery, a future where all patients have equal access to high-quality healthcare becomes a closer reality.

Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company's Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid.

GSK acquired global rights to Brexafemme, a novel antifungal from Scynexis that is approved for treating vaginal yeast infections. The deal also gives GSK the chance to commercialize the drug in other indications.

The complaint alleges multiple violations of the Valentine Act, Ohio’s antitrust law, which prohibits price fixing, controlled sales and other agreements that restrain trade and hurt competition. David Yost, the attorney general decried the practices of PBMs saying that they hurt everyday Ohioans dependent on life-saving drugs like insulin.